Caribou Biosciences Inc. (NASDAQ:CRBU) saw a downside of -6.54% to close Friday at $22.31 after subtracting -$1.56 on the day. The 5-day average trading volume is 555,080 shares of the company’s common stock. It has gained $25.46 in the past week. An average of 905,575 shares of the company has been traded in the last 20 days.
CRBU’s 1-month performance is -17.31% or -$4.67 on its low of $21.40 reached on 10/01/21. The company’s shares have touched a 52-week low of $15.00 and high of $32.65. YTD, CRBU has achieved 36.70%. However, the current price is down -31.66%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Caribou Biosciences Inc. (CRBU) has a trailing price-to-earnings (P/E) ratio of 33.74 for the broader industry and 32.48 for the sector, meaning that investors are optimistic about the stock’s future prospects. CRBU stock has a beta of 0.00.
Caribou Biosciences Inc.’s quick ratio for the period ended June 29 was 5.50, with the current ratio over the same period at 5.50 meaning that CRBU stock is able to fulfill its debt obligations. The trailing 12-month EBITDA margin is -284.96%.
The effectiveness of a company’s management is also important for investors when it comes to determining the potential profitability of the investment. Return on investment over the past year is 157.40%. In comparison, the average ROE for the broader industry over the past year is -36.91.
For the quarterly period ending June 29 this year, Analysts expected CRBU to announce $0.42 per share in earnings in its latest quarter, but it posted -$1.55, representing a -469.00% surprise. CRBU stock balance sheet for the quarter ending June 29 shows that
Let’s look briefly at Caribou Biosciences Inc. (CRBU) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 33.06% to suggest the stock is trending Neutral, with historical volatility in this time period at 76.60%.
The stock’s 5-day moving average is $23.61, reflecting a -7.96% or -$1.93 change from its current price. CRBU is currently trading -21.69% above its 20-day SMA.
Stochastic %K and %D was 15.51% and 17.75% and the average true range (ATR) pointed at 2.12. The RSI (14) points at 40.69%, while the 14-day stochastic is at 10.66% with the period’s ATR at 2.21. The stock’s 9-day MACD Oscillator is pointing at -0.83 and -1.66 on the 14-day charts.
In the most recent analyst report for Caribou Biosciences Inc. (NASDAQ: CRBU), SVB Leerink launched coverage with an Outperform rating. Analysts offering their rating for CRBU stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate CRBU as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 2 have offered a “buy” rating.
What is CRBU’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $27.00 and a high of $33.00, with their median price target at $32.00. Looking at these predictions, the average price target given by analysts is for Caribou Biosciences Inc. (CRBU) stock is $30.67.